Viking Therapeutics Rises 2.88% as Shares Remain Down for Month
The shares gained in the latest session, while Zacks consensus estimates point to a projected quarterly loss and no annual revenue.
Key takeaways
- Viking Therapeutics closed at $28.53, up 2.88% in the latest session.
- Shares lost 13.69% over the past month, according to the article.
- Zacks estimates a quarterly loss of $1 per share.
Viking Therapeutics shares rose 2.88% to close at $28.53 in the latest trading session, according to the article. The stock outperformed the S&P 500, which gained 0.6%.
The gain followed a 13.69% decline in the shares over the past month. The article said they underperformed the Medical sector, which fell 1.97%, and the S&P 500, which rose 1.34%, over that period.
Zacks estimates Viking will report a quarterly loss of $1 per share, down 23.46% from the same quarter a year earlier. For the year, its consensus estimates are a loss of $4.46 per share and revenue of $0 million.
This article was produced with the help of AI technology. Source: Yahoo Finance
